Gestational diabetes : insulin or oral hypoglycemic agents? Pilot study on women treatment preference and its influence on quality of life
Year: 2015
Type: dissertation
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: Background: The use of oral hypoglycemic agents (OHA) in gestational diabetes mellitus (GDM) is still debated. Insulin remains the first line treatment after diet failure. We hypothesized that OHA allows for better quality of life (QOL) in women with GDM and that the y prefer OHA to insulin therapy. Methods: Pilot study; 73 women with GDM were randomly assigned to the OHA group (metformin ± glyburide ± supplementary insulin, as needed) or the insulin group. General health, well-being, and treatment satisfaction using established questionnaires (SF-36, Well-Being Questionnaire and Diabetes Treatment Satisfaction Questionnaire) were respectively assessed at randomization, 38 weeks, and postpartum. Treatment preference and depression were assessed 8 weeks postpartum using the MIG questionnaire and the Short-form Edinburgh Depression Scale. Our primary outcomes were 1) preference of treatment and 2) QOL. Secondary outcomes included maternal glycemic control (hypoglycemia defined as plasma glucose < 3.3 mmol/L), as well as gestational and neonatal complications. Results: Analyses were performed in 68 women. In the OHA group (n= 34), 35.3% women received insulin therapy. More women in the OHA group than in the insulin group preferred their assigned treatment for another pregnancy (72.7% vs. 42.4%, p < 0.01) if a treatment is needed. No statistical differences between groups were found for the 3 items of QOL, the depression score, and neonatal complications. The mean rate of maternal hypoglycemia was higher in the OHA group (0. 8 vs. 0.1, p < 0.008). No statistical differences were found for other maternal and neonatal issues. Conclusion: Women declared to prefer OHA to insulin for a subsequent pregnancy complicated by GDM. QOL was similar in both groups. Use of OHA was not associated to clinically significant differences in maternal and neonatal complications.
Author: Pellerin, Marieve
Institution: Université de Sherbrooke
Language: French
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7201923179
